The Penicillins and Streptomycins in Dosage market in Kyrgyzstan experienced fluctuations in per capita value from 2013 to 2023. As of 2023, the value stood at $1.57, indicating a continuous downward trend, particularly from 2021. Over the last two years, the market showed a decreasing pattern with a year-on-year variation of approximately -11% in 2022 and -1.88% in 2023. The Compound Annual Growth Rate (CAGR) over the last five years shows an average annual decrease, reflecting declining demand or market saturation.
Future trends to watch for include potential market stabilization or recovery due to health policy changes or increased healthcare access. Monitoring pharmaceutical exports and local production capabilities will also be crucial for understanding long-term market dynamics.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 25 | 25 Malaysia | 1.87 | 2023 | View data | ||
| 26 | 26 Armenia | 1.75 | 2023 | View data | ||
| 27 | 27 Kyrgyzstan | 1.57 | 2023 | |||
| 28 | 28 Estonia | 1.55 | 2023 | View data | ||
| 29 | 29 Thailand | 1.27 | 2023 | View data | ||
